Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa.

OBJECTIVES Attrition from care among HIV infected patients can lead to poor clinical outcomes. Our objective was to evaluate hypothetical interventions seeking to improve retention-in-care (RIC) for HIV-infected patients in East Africa, asking whether they could offer favorable value compared to earlier ART initiation. METHODS We used a micro-simulation model to analyze two RIC focused strategies within an East African HIV treatment program--"risk reduction," defined as intervention(s) that decrease the risk of attrition from care; and "outreach," defined as interventions that find patients and relink them with care. We compared this to earlier ART treatment as a measure of the potential health benefits forgone (e.g., opportunity cost). RESULTS Reducing attrition by 40% at an average cost of $10 per person remains a less efficient use of resources compared to ensuring full access to ART (cost- effectiveness ratio $1300 vs $3700) for ART eligible patients. An outreach intervention had limited clinical benefit in our simulation. If intervention costs are <$10 per person, however, an intervention able to achieve a 40% (or greater) reduction in attrition may be a cost-effective next implementation option following implementation of earlier ART treatment. CONCLUSIONS Our results suggest that programs should consider retention focused programs once they have already achieved high degrees of ART coverage among eligible patients. It is important that decision makers understand the epidemiology and associated outcomes of those patients who are classified as lost to follow up in their systems prior to implementation in order to achieve the highest value.

[1]  N. Ford,et al.  Long-Term Health Care Interruptions Among HIV-Positive Patients in Uganda , 2013, Journal of acquired immune deficiency syndromes.

[2]  D. Gareta,et al.  Early active follow‐up of patients on antiretroviral therapy (ART) who are lost to follow‐up: the ‘Back‐to‐Care’ project in Lilongwe, Malawi , 2010, Tropical medicine & international health : TM & IH.

[3]  M. Egger,et al.  Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis , 2009, PloS one.

[4]  S. Rosen,et al.  Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa , 2010, Tropical medicine & international health : TM & IH.

[5]  J. Mukherjee,et al.  Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  N. Ford,et al.  Self‐transfer and mortality amongst adults lost to follow‐up in ART programmes in low‐ and middle‐income countries: systematic review and meta‐analysis , 2015, Tropical medicine & international health : TM & IH.

[7]  T. F. Rinke de Wit,et al.  Implementation of an Antiretroviral Access Program for HIV-1-Infected Individuals in Resource-Limited Settings: Clinical Results From 4 African Countries , 2007, Journal of acquired immune deficiency syndromes.

[8]  Nello Blaser,et al.  Tracing of Patients Lost to Follow-up and HIV Transmission: Mathematical Modeling Study Based on 2 Large ART Programs in Malawi , 2014, Journal of acquired immune deficiency syndromes.

[9]  Sydney Rosen,et al.  Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.

[10]  Andrew Schaefer,et al.  Influence of Alternative Thresholds for Initiating HIV Treatment on Quality-Adjusted Life Expectancy: A Decision Model , 2008, Annals of Internal Medicine.

[11]  Mark S Roberts,et al.  Estimating the proportion of patients infected with HIV who will die of comorbid diseases. , 2005, The American journal of medicine.

[12]  Gross domestic product per capita at the U.S.-Mexico border: An analysis of macroeconomic trends , 2014 .

[13]  B. Chi,et al.  Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia , 2008, AIDS care.

[14]  Jeffrey N. Martin,et al.  Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. , 2008, JAMA.

[15]  M. Weinstein,et al.  Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal , 2009, PLoS medicine.

[16]  L. Guinness,et al.  Costs of hospital care for HIV-positive and HIV-negative patients at Kenyatta National Hospital, Nairobi, Kenya , 2002, AIDS.

[17]  H. Tweya,et al.  Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi , 2011, BMC infectious diseases.

[18]  Rami Kantor,et al.  Antiretroviral Treatment Interruptions Induced by the Kenyan Postelection Crisis Are Associated With Virological Failure , 2013, Journal of acquired immune deficiency syndromes.

[19]  S. Lawn,et al.  Community Viral Load and CD4 Count Distribution Among People Living With HIV in a South African Township: Implications for Treatment as Prevention , 2013, Journal of acquired immune deficiency syndromes.

[20]  J. Hogan,et al.  A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment , 2012, Journal of the International AIDS Society.

[21]  C. Orrell,et al.  Treatment Interruption and Variation in Tablet Taking Behaviour Result in Viral Failure: A Case-Control Study from Cape Town, South Africa , 2011, PloS one.

[22]  R. Zachariah,et al.  Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  M. Lamb,et al.  High attrition before and after ART initiation among youth (15–24 years of age) enrolled in HIV care , 2014, AIDS.

[24]  Gundo Weiler,et al.  Global Update on HIV Treatment 2013: Results, Impact and Opportunities , 2013 .

[25]  L. Ivers,et al.  Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Elliott,et al.  Effects of Physical Tracing on Estimates of Loss to Follow-Up, Mortality and Retention in Low and Middle Income Country Antiretroviral Therapy Programs: A Systematic Review , 2013, PloS one.

[27]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[28]  Rob Baltussen,et al.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .

[29]  HOMAS,et al.  VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 , 2000 .

[30]  Y. Mukadi,et al.  Adherence Support Workers: A Way to Address Human Resource Constraints in Antiretroviral Treatment Programs in the Public Health Setting in Zambia , 2008, PloS one.

[31]  S. Rosen,et al.  Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review , 2011, PLoS medicine.

[32]  Elvin Geng,et al.  Implementation and Operational Research: Evaluating Outcomes of Patients Lost to Follow-up in a Large Comprehensive Care Treatment Program in Western Kenya , 2015, Journal of acquired immune deficiency syndromes.

[33]  C. Yiannoutsos,et al.  Retention in Care among HIV-Infected Patients in Resource-Limited Settings: Emerging Insights and New Directions , 2010, Current HIV/AIDS reports.

[34]  Myron S. Cohen,et al.  Universal voluntary HIV testing and immediate antiretroviral therapy , 2009, The Lancet.

[35]  C. Yiannoutsos,et al.  Retention in Care and Connection to Care among HIV-Infected Patients on Antiretroviral Therapy in Africa: Estimation via a Sampling-Based Approach , 2011, PloS one.

[36]  C. Yiannoutsos,et al.  Failure to Initiate Antiretroviral Therapy, Loss to Follow-up and Mortality Among HIV-Infected Patients During the Pre-ART Period in Uganda , 2013, Journal of acquired immune deficiency syndromes.

[37]  Nneka Emenyonu,et al.  Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach , 2010, Journal of acquired immune deficiency syndromes.

[38]  Kara Wools-Kaloustian,et al.  Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? , 2011, Journal of the International AIDS Society.

[39]  B. Strom,et al.  Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector , 2006, AIDS.

[40]  H. Ramroth,et al.  Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  J. Lawrence,et al.  Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults. , 2006, The Cochrane database of systematic reviews.

[42]  C. Dye,et al.  Universal voluntary HIV testing and immediate antiretroviral therapy – Authors' reply , 2009, The Lancet.

[43]  G. John-Stewart,et al.  Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya , 2011, AIDS.

[44]  M. Egger,et al.  Are They Really Lost? “True” Status and Reasons for Treatment Discontinuation among HIV Infected Patients on Antiretroviral Therapy Considered Lost to Follow Up in Urban Malawi , 2013, PloS one.

[45]  Nneka Emenyonu,et al.  Tracking a sample of patients lost to follow‐up has a major impact on understanding determinants of survival in HIV‐infected patients on antiretroviral therapy in Africa , 2010, Tropical medicine & international health : TM & IH.

[46]  N. Ford,et al.  Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings – a systematic review , 2014, Journal of the International AIDS Society.

[47]  J. Lawrence,et al.  Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults. , 2005, The Cochrane database of systematic reviews.

[48]  Glenn J. Wagner,et al.  Electronic Medical Records and Same Day Patient Tracing Improves Clinic Efficiency and Adherence to Appointments in a Community Based HIV/AIDS Care Program, in Uganda , 2012, AIDS and Behavior.

[49]  Sydney Rosen,et al.  Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review , 2010, Tropical medicine & international health : TM & IH.

[50]  W. El-Sadr,et al.  Association of Adherence Support and Outreach Services with Total Attrition, Loss to Follow-Up, and Death among ART Patients in Sub-Saharan Africa , 2012, PloS one.

[51]  Jonathan D. Cohen,et al.  Universal voluntary HIV testing and immediate antiretroviral therapy , 2009, The Lancet.

[52]  B. Eley,et al.  Improved Survival and Antiretroviral Treatment Outcomes in Adults Receiving Community-Based Adherence Support: 5-Year Results From a Multicentre Cohort Study in South Africa , 2012, Journal of acquired immune deficiency syndromes.

[53]  M. Fox,et al.  Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa , 2010, Tropical medicine & international health : TM & IH.

[54]  S. Lawn,et al.  Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa , 2010, Tropical medicine & international health : TM & IH.